Read more
9:22 PM · 2 January 2023

Tesla falls short of analysts' expectations. Q4 deliveries below forecasts

Tesla reported that deliveries for the fourth quarter of 2022 totaled 405,278 vehicles against expectations of 420,760 vehicles. Model S and Model X deliveries totaled 17,147 units against expectations of 18,578 units. 

As for the production of new vehicles, here the figures fare better. The company produced 439,701 vehicles in Q4 against 438,840 expected by analysts surveyed by Bloomberg. Production of S/X models totaled 20,613 versus 18,611 expected, and 3 and Y models totaled 419,088 versus 411,828 expected. 

Deliveries and production in Q4 2022. source: Bloomberg

7 May 2026, 9:46 PM

Daily Summary: A shift in sentiment at the end of the day 💥⬇️

7 May 2026, 5:50 PM

Stock of the Week AMD: From second choice to core pillar of the AI infrastructure

7 May 2026, 5:46 PM

US OPEN: Wall Street opens higher 🔼 Datadog and ARM in the spotlight 💥

7 May 2026, 3:51 PM

Rheinmetall earninigs: Weak sales overshadow strong prospects

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.